There are several potential pathophysiological and molecular mechanisms linking T2DM and CRC, including hyperinsulinemia, insulin-like growth factor (IGF) axis, hyperglycemia, obesity, chronic inflammation, cytokines, adipokines, and exposure to fecal carcinogens. The gene discussed is IGF1; the disease is hyperinsulinism.